Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Response of Haemodialysis Patients to BNT162b2 mRNA Cov-19 Vaccine

NCT04881396 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

NCT NCT04881396
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04881396 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Response of Haemodialysis Patients to BNT162b2 mRNA Cov-19 Vaccine
Lead sponsor
Hospices Civils de Lyon
Phase
Observational
Overall status
Completed
Start date
May 10, 2021
Completion date
February 15, 2022
Enrollment
99 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 vaccines, hemodialysis complication